Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma

A. Younes; F. Wong

doi:10.1093/annonc/mdp277

Experience with ⁹⁰Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma

A. Younes, F. Wong

Nuclear Medicine

Research output: Contribution to journal › Comment/debate › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	1147-1148
Number of pages	2
Journal	Annals of Oncology
Volume	20
Issue number	6
DOIs	https://doi.org/10.1093/annonc/mdp277
State	Published - 2009

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdp277

Cite this

@article{6ff71af9d0f54ed08f92bbf8138d728f,

title = "Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma",

author = "A. Younes and F. Wong",

year = "2009",

doi = "10.1093/annonc/mdp277",

language = "English (US)",

volume = "20",

pages = "1147--1148",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma

AU - Younes, A.

AU - Wong, F.

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=66149155829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149155829&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdp277

DO - 10.1093/annonc/mdp277

M3 - Comment/debate

C2 - 19465429

AN - SCOPUS:66149155829

SN - 0923-7534

VL - 20

SP - 1147

EP - 1148

JO - Annals of Oncology

JF - Annals of Oncology

IS - 6

ER -

Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Experience with ⁹⁰Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma